Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico 
Oil Prices Rise as Hormuz Reopening Remains Uncertain 
Treasury Wine Estates Shares Jump as U.S. Overhaul Lifts FY2026 Outlook 
Apple Tests China’s CXMT Memory Chips for iPhones and MacBooks Amid AI Supply Crunch 
Nvidia Secures $500 Billion AI Infrastructure Push With Wall Street Giants 
US Yen Intervention Unlikely to Deliver Lasting Recovery, Yardeni Says 
Asian Stocks Rise as Weak US Jobs Data Eases Fed Rate Hike Fears 
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks 
Anthropic Signs $9.1B AI Data Center Deal With Riot Platforms 
UK Retail Sales Rise as World Cup and Heatwave Boost Food, Pubs and Clothing 
Asian Currencies Steady as Markets Await U.S. Inflation Data 
Gold Prices Hold Near Seven-Week High as Markets Await U.S. Inflation Data 
Iran-Oman Near Strait of Hormuz Deal as Shipping Tensions Persist 
Sony, TSMC Eye $6.3 Billion Japan Chip Venture for Next-Gen Image Sensors 
US Stock Futures Flat as Iran Strait of Hormuz Demands Fuel Oil Concerns 
JPMorgan Plans More Asia-Pacific Hiring in 2027 as Corporate Banking Revenue Surges 
GSK Consumer Healthcare Korea was revealed to have appointed a new chief executive officer, and it was revealed to be Shin Dong Woo, a former CEO of the company’s branch in Hong Kong.
According to The Korea Times, GSK Consumer Healthcare Korea announced the assignment of CEO Shin earlier this week. It was reported that the new chief has been with the company for 28 years and has led GSK in various international businesses - from consumer health care to general consumer goods.
He also led other health care firms such as Pfizer and Sanofi. Prior to his assignment as the new chief at GSK Consumer Healthcare Korea, he has been leading the Honk Kong unit for the last two years. During his tenure, he has many achievements, including boosting the business and building the foundation for its stability.
At Sanofi Korea, he became the first president of the He also completed the company's integration with Pfizer Consumer Healthcare, where he was CEO of the Korean branch and the Asia-Pacific region between 2015 and 2020.
Shin also became the very first president of the French multinational healthcare company’s Korean unit. He helped established the brand in the country and introduced major products that are now selling very well here., and this is not all. Shin has extensive experience in marketing as well as he worked at Coca-Cola, L’Oreal, and Fox Home Entertainment and was in charge of marketing and sales for more than a decade.
Meanwhile, Shin will lead GSK Consumer Healthcare Korea, which has recently changed its name to Haleon. This will be the company’s official name as it starts its consumer healthcare venture. The name means the company will also change all of its product packaging.
"With the announcement of 'Haleon' today, we are one step closer to our goal of becoming a consumer healthcare company,” Haleon’s CEO-nominee, Brian McNamara, said in a press release in February. “'Haleon' will stand as a leader in the consumer healthcare industry with the vision of delivering better daily health to mankind.”
“Haleon” is the outcome of the successful merging of Novartis in 2015 and Pfizer's consumer healthcare portfolio in 2019 over the past eight years.
